Mutual Of America Capital Management LLC Vaxcyte, Inc. Transaction History
Mutual Of America Capital Management LLC
- $9.01 Billion
- Q2 2024
A detailed history of Mutual Of America Capital Management LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 50,813 shares of PCVX stock, worth $5.92 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
50,813
Previous 44,699
13.68%
Holding current value
$5.92 Million
Previous $3.05 Million
25.65%
% of portfolio
0.04%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding PCVX
# of Institutions
286Shares Held
110MCall Options Held
248KPut Options Held
109K-
Black Rock Inc. New York, NY9.94MShares$1.16 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.8MShares$1.14 Billion0.01% of portfolio
-
Janus Henderson Group PLC London, X08.87MShares$1.03 Billion0.37% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.2MShares$955 Million9.34% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$535 Million0.06% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $6.91B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...